# MNOV (Medicinova, Inc.) - SEC EDGAR Financial Statements

> Medicinova, Inc. reported $410K in revenue and a net loss of $10.55M for the fiscal year ended December 31, 2025, with a -2814.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/MNOV
- Markdown: https://convexityos.com/fundamentals/MNOV.md
- SEC CIK: 0001226616
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001226616&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $410K | Dec 31, 2025 |
| Operating Income | FY 2025 | -$11.53M | -2814.5% margin |
| Net Income | FY 2025 | -$10.55M | -2574.3% net margin |
| Diluted EPS | FY 2025 | -$0.21 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$9.80M | -2393.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $29.26M | Total debt: $591K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $410K | -- | $1.00M | -- | $4.04M | -- | -- | -- | -- | -- |
| Research & Development | $6.70M | $6.80M | $5.30M | $8.70M | $8.10M | $7.10M | $5.70M | $5.30M | $3.90M | $3.10M |
| Selling, General & Admin | $6.54M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $13.69M | $12.68M | $10.90M | $14.63M | $14.25M | $14.18M | $14.03M | $15.59M | $13.03M | $10.88M |
| **Operating Income** | -$13.28M | -$12.68M | -$9.90M | -$14.63M | -$10.22M | -$14.18M | -$14.03M | -$15.59M | -$13.03M | -$10.88M |
| **EBITDA** | -$13.26M | -$12.65M | -$9.88M | -$14.61M | -$10.19M | -$14.16M | -$14.01M | -$15.56M | -$13.00M | -$10.87M |
| Interest Income | $1.30M | $1.67M | $1.83M | $810K | $144K | $361K | $1.15M | $940K | $146K | $67K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $298 | $454 |
| Income Before Tax | -$11.99M | -$11.04M | -$8.57M | -$14.07M | -$10.13M | -$13.86M | -$12.93M | -$14.67M | -$12.91M | -$10.86M |
| Income Tax Expense | $6.0K | $5.5K | $3.0K | $2.8K | $2.6K | -$1.6K | $13K | $5.3K | -$1.74M | $3.8K |
| **Net Income** | -$12.00M | -$11.05M | -$8.57M | -$14.07M | -$10.13M | -$13.85M | -$12.94M | -$14.68M | -$11.16M | -$10.87M |
| Basic EPS | -$0.24 | -$0.23 | -$0.17 | -$0.29 | -$0.21 | -$0.31 | -$0.30 | -$0.36 | -$0.32 | -$0.33 |
| **Diluted EPS** | -$0.24 | -$0.23 | -$0.17 | -$0.29 | -$0.21 | -$0.31 | -$0.30 | -$0.36 | -$0.32 | -$0.33 |
| Basic Shares Outstanding | 49.1M | 49.0M | 49.0M | 49.0M | 48.6M | 44.4M | 43.2M | 41.1M | 35.1M | 33.0M |
| Diluted Shares Outstanding | 49.1M | 49.0M | 49.0M | 49.0M | 48.6M | 44.4M | 43.2M | 41.1M | 35.1M | 33.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $139K | $458K | $187K | -- | $123K | $135K | -- | -- |
| Research & Development | $1.10M | $900K | $1.20M | $1.40M | $1.50M | $2.00M | $1.70M | $1.80M |
| Selling, General & Admin | $1.95M | $1.97M | $1.76M | -- | $1.92M | $1.55M | -- | -- |
| Total Operating Expenses | $3.20M | $3.00M | $3.02M | $3.24M | $3.50M | $3.74M | $3.20M | $3.18M |
| **Operating Income** | -$3.06M | -$2.54M | -$2.84M | -$3.09M | -$3.38M | -$3.61M | -$3.20M | -$3.18M |
| **EBITDA** | -$3.06M | -$2.54M | -$2.83M | -$3.09M | -$3.38M | -$3.60M | -$3.20M | -$3.18M |
| Interest Income | $219K | $232K | $253K | $302K | $341K | $325K | $336K | $390K |
| **Net Income** | -$2.84M | -$2.31M | -$2.59M | -$2.80M | -$3.05M | -$3.28M | -$2.86M | -$2.81M |
| Basic EPS | -$0.06 | -$0.05 | -$0.05 | -- | -$0.06 | -$0.07 | -$0.06 | -- |
| **Diluted EPS** | -$0.06 | -$0.05 | -$0.05 | -- | -$0.06 | -$0.07 | -$0.06 | -- |
| Basic Shares Outstanding | 49.4M | 49.2M | 49.2M | -- | 49.0M | 49.0M | 49.0M | -- |
| Diluted Shares Outstanding | 49.4M | 49.2M | 49.2M | -- | 49.0M | 49.0M | 49.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.81M | $40.36M | $51.00M | $18.51M | $71.43M | $60.04M | $63.79M | $62.31M | $27.99M | $24.12M |
| Short-Term Investments | -- | -- | -- | $39.98M | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $30.81M | $40.36M | $51.00M | $58.49M | $71.43M | $60.04M | $63.79M | $62.31M | $27.99M | $24.12M |
| Accounts Receivable, Net | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $30.99M | $41.07M | $51.17M | $58.99M | $72.01M | $60.72M | $64.30M | $62.76M | $28.33M | $24.70M |
| Property, Plant & Equipment, Net | $8.3K | $26K | $46K | $45K | $58K | $56K | $41K | $53K | $63K | $91K |
| Goodwill | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M |
| Other Non-Current Assets | $19K | $19K | $74K | $93K | $115K | $75K | $460K | $11K | $11K | -- |
| **Total Non-Current Assets** | $14.61M | $14.80M | $15.10M | $15.17M | $15.40M | $14.70M | $14.90M | $14.46M | $15.09M | $15.11M |
| **Total Assets** | $45.60M | $55.88M | $66.27M | $74.15M | $87.41M | $75.42M | $79.21M | $77.22M | $43.42M | $39.81M |
| Accounts Payable | $625K | $1.10M | $1.00M | $425K | $403K | $617K | $451K | $617K | $1.52M | $367K |
| Deferred Revenue (Current) | $370K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $3.80M | $2.96M | $3.28M | $3.19M | $2.83M | $2.19M | $2.23M | $2.19M | $2.88M | $1.63M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $1.69M | $1.69M | $1.69M | $1.69M | $1.69M |
| Other Non-Current Liabilities | $17K | $211K | $411K | $524K | $695K | $2.7K | $186K | $27K | -- | -- |
| **Total Non-Current Liabilities** | $219K | $413K | $612K | $725K | $896K | $1.90M | $2.08M | $1.92M | $1.90M | $3.65M |
| **Total Liabilities** | $4.02M | $3.37M | $3.89M | $3.91M | $3.73M | $4.09M | $4.31M | $4.12M | $4.78M | $5.28M |
| **Total Debt (incl. Leases)** | $211K | $405K | $627K | $681K | $827K | $189K | $399K | -- | -- | -- |
| Common Stock | $49K | $49K | $49K | $49K | $49K | $45K | $44K | $42K | $36K | $35K |
| Retained Earnings | -$438.7M | -$426.8M | -$415.7M | -$407.1M | -$393.1M | -$382.9M | -$369.1M | -$356.1M | -$341.5M | -$330.3M |
| Accumulated Other Comp. Income | -$127K | -$135K | -$118K | -$115K | -$99K | -$88K | -$93K | -$93K | -$95K | -$96K |
| **Total Stockholders' Equity** | $41.59M | $52.50M | $62.38M | $70.24M | $83.68M | $71.33M | $74.89M | $73.11M | $38.64M | $34.53M |
| Total Equity | $41.59M | $52.50M | $62.38M | $70.24M | $83.68M | $71.33M | $74.89M | $73.11M | $38.64M | $34.53M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $29.26M | $25.42M | $27.33M | $30.81M | $32.56M | $34.26M | $36.57M | $40.36M |
| **Cash & Short-Term Investments** | $29.26M | $25.42M | $27.33M | $30.81M | $32.56M | $34.26M | $36.57M | $40.36M |
| Accounts Receivable, Net | $601K | $0 | $245K | $0 | $0 | $135K | -- | $0 |
| **Total Current Assets** | $30.23M | $25.92M | $28.15M | $30.99M | $32.92M | $35.12M | $37.68M | $41.07M |
| Property, Plant & Equipment, Net | $6.5K | $9.8K | $15K | $8.3K | $13K | $15K | $20K | $26K |
| Goodwill | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M | $9.60M |
| Other Non-Current Assets | $19K | $0 | $0 | $19K | $19K | $19K | $19K | $19K |
| **Total Non-Current Assets** | $15.01M | $14.51M | $14.56M | $14.61M | $14.66M | $14.70M | $14.75M | $14.80M |
| **Total Assets** | $45.24M | $40.43M | $42.70M | $45.60M | $47.58M | $49.82M | $52.43M | $55.88M |
| Accounts Payable | $900K | $951K | $852K | $625K | $746K | $569K | $719K | $1.10M |
| Deferred Revenue (Current) | $432K | $0 | $428K | $370K | $522K | -- | -- | -- |
| **Total Current Liabilities** | $3.46M | $2.96M | $3.10M | $3.80M | $3.34M | $2.65M | $2.13M | $2.96M |
| Other Non-Current Liabilities | $490K | $0 | $0 | $17K | $74K | $117K | $165K | $211K |
| **Total Non-Current Liabilities** | $692K | $202K | $202K | $219K | $276K | $319K | $367K | $413K |
| **Total Liabilities** | $4.15M | $3.16M | $3.30M | $4.02M | $3.61M | $2.97M | $2.50M | $3.37M |
| **Total Debt (incl. Leases)** | $591K | $117K | $165K | $211K | $255K | $302K | $355K | $405K |
| Common Stock | $51K | $49K | $49K | $49K | $49K | $49K | $49K | $49K |
| Retained Earnings | -$446.5M | -$443.6M | -$441.3M | -$438.7M | -$435.9M | -$432.9M | -$429.6M | -$426.8M |
| Accumulated Other Comp. Income | -$127K | -$127K | -$128K | -$127K | -$127K | -$127K | -$130K | -$135K |
| **Total Stockholders' Equity** | $41.09M | $37.27M | $39.41M | $41.59M | $43.96M | $46.86M | $49.93M | $52.50M |
| Total Equity | $41.09M | $37.27M | $39.41M | $41.59M | $43.96M | $46.86M | $49.93M | $52.50M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.00M | -$11.05M | -$8.57M | -$14.07M | -$10.13M | -$13.85M | -$12.94M | -$14.68M | -$11.16M | -$10.87M |
| Depreciation & Amortization | $20K | $21K | $20K | $18K | $26K | $21K | $24K | $26K | $28K | $14K |
| Stock-Based Compensation | $829K | $1.19M | $711K | $643K | $1.72M | $3.18M | $4.11M | $6.33M | $4.47M | $3.97M |
| **Operating Cash Flow** | -$9.81M | -$10.64M | -$7.43M | -$12.91M | -$9.38M | -$10.83M | -$9.12M | -$9.11M | -$6.92M | -$6.55M |
| Capital Expenditure | -$2.9K | -$895 | -$21K | -$5.0K | -$29K | -$36K | -$11K | -$10K | -- | -$84K |
| **Free Cash Flow** | -$9.81M | -$10.64M | -$7.45M | -$12.92M | -$9.41M | -$10.86M | -$9.14M | -$9.12M | -- | -$6.63M |
| **Investing Cash Flow** | -$2.9K | -$697 | $39.91M | -$40.01M | -$29K | -$36K | -$11K | $626K | -- | -$84K |
| Common Stock Issued | $244K | $0 | -- | -- | -- | -- | -- | -- | -- | $88K |
| **Financing Cash Flow** | $244K | $0 | -- | $7.9K | $20.78M | $7.11M | $10.62M | $42.81M | $10.80M | $8.67M |
| **Net Change in Cash** | -$9.55M | -$10.64M | $32.49M | -$52.93M | $11.39M | -$3.76M | $1.48M | $34.32M | $3.87M | $2.04M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.84M | -$2.31M | -$2.59M | -$2.80M | -$3.05M | -$3.28M | -$2.86M | -$2.81M |
| Depreciation & Amortization | $3.4K | $5.0K | $4.3K | $4.6K | $5.3K | $5.1K | $5.2K | $5.2K |
| Stock-Based Compensation | $431K | $177K | $408K | $181K | $158K | $205K | $286K | $264K |
| Change in Receivables | -$601K | $245K | -$245K | -- | $135K | -$135K | $0 | -- |
| **Operating Cash Flow** | -$2.39M | -$1.92M | -$3.47M | -$2.02M | -$1.70M | -$2.31M | -$3.78M | -$1.93M |
| Capital Expenditure | $0 | $0 | -$11K | $0 | -$2.9K | $0 | $0 | -- |
| **Free Cash Flow** | -$2.39M | -$1.92M | -$3.48M | -$2.02M | -$1.71M | -$2.31M | -$3.78M | -- |
| **Investing Cash Flow** | $0 | $0 | -$11K | $0 | -$2.9K | $0 | $0 | -- |
| **Net Change in Cash** | $3.84M | -$1.91M | -$3.48M | -$1.76M | -$1.70M | -$2.31M | -$3.79M | -$1.92M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -3242.5% | -- | -990.0% | -- | -253.0% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -2928.8% | -- | -857.2% | -- | -251.0% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -28.9% | -21.0% | -13.7% | -20.0% | -12.1% | -19.4% | -17.3% | -20.1% | -28.9% | -31.5% |
| Return on Assets (ROA) | -26.3% | -19.8% | -12.9% | -19.0% | -11.6% | -18.4% | -16.3% | -19.0% | -25.7% | -27.3% |
| Current Ratio | 8.16x | 13.88x | 15.61x | 18.51x | 25.42x | 27.67x | 28.86x | 28.63x | 9.83x | 15.16x |
| Quick Ratio | 8.11x | 13.64x | 15.55x | 18.35x | 25.21x | 27.36x | 28.63x | 28.43x | 9.72x | 14.80x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | +12856.7% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -25.7% | -28.9% | -29.7% | -28.9% | -27.3% | -25.2% | -22.3% | -21.0% |
| Return on Assets (ROA) | -23.3% | -26.6% | -27.4% | -26.3% | -25.2% | -23.7% | -21.3% | -19.8% |
| Current Ratio | 8.75x | 8.75x | 9.09x | 8.16x | 9.86x | 13.26x | 17.66x | 13.88x |
| Quick Ratio | 8.64x | 8.58x | 8.91x | 8.11x | 9.76x | 12.99x | 17.14x | 13.64x |
| Debt to Equity | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | +12.4% | +240.6% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
